Evidence map›Paper›PMID 41090057›Full record

ArticleClinical case reports2025

Sepsis-Induced Anti-Amphiphysin Antibody-Associated Paraneoplastic Syndrome: A Case Report.

Dexin Min, Meng Yuan, Chenda Feng, Wenjing Tang, Lichao Sun

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dexin MinDepartment of Emergency Medicine The First Hospital of Jilin University Changchun Jilin China.
Meng YuanDepartment of Emergency Medicine The First Hospital of Jilin University Changchun Jilin China.
Chenda FengDepartment of Emergency Medicine The First Hospital of Jilin University Changchun Jilin China.
Wenjing TangDepartment of Emergency Medicine The First Hospital of Jilin University Changchun Jilin China.
Lichao SunDepartment of Emergency Medicine The First Hospital of Jilin University Changchun Jilin China.ORCID https://orcid.org/0000-0002-5660-2102

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a severe systemic response to infection that can induce a variety of complications, including paraneoplastic syndrome (PNS). Anti-amphiphysin antibody-associated PNS is a rare autoimmune disorder associated with tumors. We review the case of a 27-year-old man who presented with a 3-day history of fever, disturbance of consciousness, and oliguria. After 3 weeks of intensive care unit admissions, the muscle strength of his limbs gradually decreased to grade 0. The cerebrospinal fluid (CSF) specimen revealed elevated protein, and electromyography showed peripheral nerve damage. The blood test for anti-amphiphysin antibody titer resulted positive (1:30, RI < 1:30). Sepsis, diabetic ketoacidosis, and multiple organ dysfunction syndrome (MODS) were followed by anti-amphiphysin antibody-associated PNS. He was treated with methylprednisolone and immunoglobulin. Rehabilitation therapy was initiated after discharge. One year of follow-up indicated muscle strength at grade 4 with normal muscle tone, and chest CT did not reveal any pulmonary tumors. Anti-amphiphysin antibodies are usually associated with neurologic diseases and are rarely related to sepsis. We aim to raise awareness of sepsis-induced anti-amphiphysin antibody-associated paraneoplastic syndrome, which has a poor prognosis and a high case fatality rate. Early recognition and treatment are essential to improve the prognosis.

Indexed as

anti‐amphiphysin antibodycase reportparaneoplastic syndromerhabdomyolysis syndromesepsis

Identifiers

PMID41090057
PMCPMC12515695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.